SH3BP2 Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P78314 |
---|---|
Clone Names | 100525230 |
Gene ID | 6452 |
---|---|
Other Names | SH3 domain-binding protein 2, 3BP-2, SH3BP2, 3BP2 |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | SH3BP2 |
---|---|
Synonyms | 3BP2 |
Function | Binds differentially to the SH3 domains of certain proteins of signal transduction pathways. Binds to phosphatidylinositols; linking the hemopoietic tyrosine kinase fes to the cytoplasmic membrane in a phosphorylation dependent mechanism. |
Tissue Location | Expressed in a variety of tissues including lung, liver, skeletal muscle, kidney and pancreas |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
The protein encoded by this gene has an N-terminalpleckstrin homology (PH) domain, an SH3-binding proline-richregion, and a C-terminal SH2 domain. The protein binds to the SH3domains of several proteins including the ABL1 and SYK proteintyrosine kinases , and functions as a cytoplasmic adaptor proteinto positively regulate transcriptional activity in T, naturalkiller (NK), and basophilic cells. Mutations in this gene result incherubism. Multiple transcript variants encoding different isoformshave been found for this gene.
References
Lietman, S.A., et al. J. Orthop. Res. 28(11):1425-1430(2010)Rose, J.E., et al. Mol. Med. 16 (7-8), 247-253 (2010) :Davila, S., et al. Genes Immun. 11(3):232-238(2010)Amaral, F.R., et al. J. Oral Pathol. Med. 39(3):269-274(2010)Shukla, U., et al. J. Biol. Chem. 284(49):33719-33728(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.